{"id":"W4388737168","doi":"10.1111/obr.13663","title":"Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists","year":2023,"lang":"en","type":"review","venue":"Obesity Reviews","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; Manitoba Health; Cardiome (Canada); University of British Columbia; Island Health; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly Canada; Novo Nordisk; Novo Nordisk Canada; AstraZeneca; Eli Lilly and Company","keywords":"Type 2 diabetes; Medicine; Liraglutide; Nonalcoholic fatty liver disease; Steatohepatitis; Glucagon-like peptide 1 receptor; Fatty liver; Obesity; Diabetes mellitus; Internal medicine; Bioinformatics; Pharmacology; Endocrinology; Disease; Receptor; Agonist; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009934987,0.0004869446,0.0007413028,0.0006718824,0.0003607124,0.0008152145,0.0005301759,0.0008712034,0.004597445],"category_scores_gemma":[0.0007666317,0.0001421658,0.001124896,0.0004255956,0.0003473733,0.001039517,0.0008309833,0.001947678,0.001540857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004020146,"about_ca_system_score_gemma":0.0008162483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005750046,"about_ca_topic_score_gemma":0.001335016,"domain_scores_codex":[0.9994386,0.0001608019,0.00008117569,0.00006399969,0.0001698284,0.00008563108],"domain_scores_gemma":[0.9996891,0.00006579608,0.00009625657,0.00002382456,0.00006884909,0.00005612974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002229064,0.0009675268,0.003153084,0.004552927,0.0002568065,0.001190526,0.0001596208,0.0006613763,0.0237106,0.0045532,0.01834683,0.9402184],"study_design_scores_gemma":[0.001908918,0.01056627,0.01811395,0.007536877,0.001163786,0.01447433,0.0005345167,0.002328723,0.0422587,0.01287846,0.8880917,0.0001437643],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06292661,0.8363342,0.03490622,0.01970455,0.00203716,0.0007802779,0.001005011,0.000824326,0.04148168],"genre_scores_gemma":[0.2798034,0.6350681,0.04637747,0.0140824,0.003255995,0.001072655,0.002074438,0.0001631799,0.01810233],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004597445,"threshold_uncertainty_score":0.01538002,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06433320283290306,"score_gpt":0.3341029985553939,"score_spread":0.2697697957224908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}